Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer
1541.2000 -12.20 (-0.79%)
NSE Sep 08, 2025 15:31 PM
Volume: 588.5K
 

logo
Cipla Ltd.
09 Nov 2017
1541.20
-0.79%
IDBI Capital
Total revenues for Q2FY18 were at Rs40.8bn (est. Rs40bn) were down 8.8% YoY and 15.8% QoQ. Gross margins dipped to 62% lowest since Q1FY17, we expect these to ramp up to ~63.5-64% going forward. PAT was up 20.6% at Rs4.1bn, Adj PAT was up 19.3% YoY while down 33.4% QoQ mainly due to lower other income and substantial increase in depreciation and interest (all one-off). Given domestic business has significantly normalized and only price related pain in the US market (~USD2-3mn) we expect the balance year to pan out better. Given most of the regions supporting growth, improvement in the sales mix to...
Deven Choksey released a Hold report for Cipla Ltd. with a price target of 1570.0 on 08 Sep, 2025.
More from Cipla Ltd.
Recommended